Otlang, Aimee .
HRN: 23-95-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2023
METRONIDAZOLE 500MG (TAB)
10/24/2023
10/30/2023
PO
500mg
TID
THICKLY MSAF
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes